Evaluation of the comparative efficacy and safety of obinutuzumab and other follow-up strategies after rituximab failure in refractory nephrotic syndrome

Pediatric Nephrology 2026

View at publisher

Authors: Haoyu Zha, C Y Chen, Juan Tu, Ling Wan

DOI: 10.1007/s00467-026-07445-w

Cited by: 1

References: 28

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Renal Transplantation Outcomes and Treatments Vasculitis and related conditions

References 28